6-Fluoroquinazoline-2,4-diol is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting enzyme inhibition. Its structure is often employed in the development of anticancer agents, as it can be incorporated into molecules designed to inhibit tyrosine kinases, which play a critical role in cancer cell proliferation. Additionally, this compound is explored for its potential in creating antimicrobial agents, given its ability to interfere with bacterial DNA replication and repair processes. Researchers also investigate its use in designing drugs for treating inflammatory and autoimmune diseases due to its potential to modulate specific biochemical pathways. Overall, its versatility makes it a valuable building block in drug discovery and development.